C/EBPβ mediates synergistic upregulation of gene expression by interferon-γ and tumor necrosis factor-a in bone marrow-derived mesenchymal stem cells

Stem Cells

Volumn 27, Issue 4, 2009, Pages 942-948

  Xu, Guangwu ^a   Zhang, Yingyu ^a   Zhang, Liying ^a   Roberts, Arthur I ^a   Shi, Yufang ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

C EBP beta; IFN ; Mesenchymal stem cells; TNF

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CXCL1 CHEMOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RANTES; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL ACTIVITY; CONTROLLED STUDY; GENE EXPRESSION; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHEMOKINE CCL5; CHEMOKINE CXCL1; GENE EXPRESSION; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-6; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 65649106109     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.22     Document Type: Article

References (29)

1. Chamberlain G, Fox J, Ashton B et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25: 2739-2749.
2. Kuznetsov SA, Krebsbach PH, Satomura K et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997;12:1335-1347. (Pubitemid 27375376)
3. Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006;36:2566-2573. (Pubitemid 44608440)
4. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007;211:27-35. (Pubitemid 46363893)
5. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:321-334. (Pubitemid 40542924)
6. Ren G, Zhang L, Zhao X et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008;2:141-150.
7. Chamberlain G, Fox J, Ashton B et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25: 2739-2749.
8. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 2008;214: 149-160.
9. Sanceau J, Wijdenes J, Revel M et al. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J Immunol 1991;147:2630-2637.
10. Hattori A, Iwasaki S, Murase K et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-gamma in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994;340:177-180.
11. Oh I, Ozaki K, Sato K et al. Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells. Biochem Biophys Res Commun 2007;355:956-962. (Pubitemid 46366921)
12. Li H, Gade P, Xiao W et al. The interferon signaling network and transcription factor C/EBP-beta. Cell Mol Immunol 2007;4:407-418.
13. Ranjan P, Boss JM. C/EBPbeta regulates TNF induced MnSOD expression and protection against apoptosis. Apoptosis 2006;11:1837-1849. (Pubitemid 44371056)
14. Akira S, Isshiki H, Sugita T et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990;9:1897-1906. (Pubitemid 20170023)
15. Xu G, Zhang L, Ren G et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res 2007;17: 240-248. (Pubitemid 46438724)
16. English K, Barry FP, Field-Corbett CP et al. IFN-gamma and TNFalpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 2007;110:91-100. (Pubitemid 46830943)
17. Ryan JM, Barry F, Murphy JM et al. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007;149:353-363. (Pubitemid 47063057)
18. Chan JL, Tang KC, Patel AP et al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 2006;107:4817-4824. (Pubitemid 43882633)
19. Krampera M, Cosmi L, Angeli R et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006;24:386-398. (Pubitemid 44464808)
20. Xu G, Zhang Y, Zhang L et al. The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells. Biochem Biophys Res Commun 2007;361:745-750. (Pubitemid 47238033)
21. Djouad F, Charbonnier LM, Bouffi C et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6- dependent mechanism. Stem Cells 2007;25:2025-2032. (Pubitemid 47258180)
22. Takami Y, Motoki T, Yamamoto I et al. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma. Biochem Biophys Res Commun 2005;327:212-217. (Pubitemid 40051373)
23. Proost P, Verpoest S, Van de Borne K et al. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J Leukoc Biol 2004;75:777-784. (Pubitemid 38584572)
24. Jorens PG, Van Overveld FJ, Vermeire PA et al. Synergism between interleukin-1 beta and interferon-gamma, an inducer of nitric oxide synthase, in rat lung fibroblasts. Eur J Pharmacol 1992;224:7-12.
25. Sekine N, Ishikawa T, Okazaki T et al. Synergistic activation of NFkappab and inducible isoform of nitric oxide synthase induction by interferon-gamma and tumor necrosis factor-alpha in INS-1 cells. J Cell Physiol 2000;184:46-57. (Pubitemid 30349627)
26. Lee AH, Hong JH, Seo YS. Tumour necrosis factor-alpha and interferon- gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J 2000;350 (Part 1):131-138.(Part 1)
27. Roy SK, Wachira SJ, Weihua X et al. CCAAT/enhancer-binding protein- beta regulates interferon-induced transcription through a novel element. J Biol Chem 2000;275:12626-12632. (Pubitemid 30241411)
28. Durbin JE, Hackenmiller R, Simon MC et al. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996;84:443-450. (Pubitemid 26058569)
29. Meraz MA, White JM, Sheehan KC et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996;84:431-442. (Pubitemid 26058568)